Kinematic Real Time Feedback Used to Learn Manual Therapy on Peripherical Joints

May 11, 2016 updated by: Dr. Antonio I Cuesta-Vargas, University of Malaga

Kinematic Real-Time Feedback, Obtained by Inertial Sensors, Used to Learn Manual Therapy on Peripherical Joints

This study will try to analyze the effect of the real-time kinematic feedback (KRTF) to learn manual therapy on peripherical joints comparing the results with the traditional teaching method.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Málaga, Spain, 29071
        • Antonio I Cuesta-Vargas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • undergraduate students with no experience in manual therapy

Exclusion Criteria:

  • To have some experience in manual therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Traditional Learning System
Traditional systems of manual therapy teaching
Other: Traditional systems of manual therapy teaching
Experimental: Kinematic Real-Time Feedback
Kinematic real time feedback to learn Manual therapy
Device: Kinematic Real Time Feedback

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Manipulation time Score
Time Frame: Baseline
Manipulation time Score: Seconds
Baseline
Manipulation time Score
Time Frame: One Lesson
Manipulation time Score: Seconds
One Lesson
Manipulation time Score
Time Frame: One week
Manipulation time Score: Seconds
One week
Manipulation time Score
Time Frame: Four weeks
Manipulation time Score: Seconds
Four weeks
Manipulation time Score
Time Frame: Three months
Manipulation time Score: Seconds
Three months
Manipulation time Score
Time Frame: Six Months
Manipulation time Score: Seconds
Six Months
Manipulation Displacement Score
Time Frame: Baseline
Joint Displacement Score: Degrees and centimeter
Baseline
Manipulation Displacement Score
Time Frame: One Lesson
Joint Displacement Score: Degrees and centimeter
One Lesson
Manipulation Displacement Score
Time Frame: One week
Joint Displacement Score: Degrees and centimeter
One week
Manipulation Displacement Score
Time Frame: Four weeks
Joint Displacement Score: Degrees and centimeter
Four weeks
Manipulation Displacement Score
Time Frame: Three months
Joint Displacement Score: Degrees and centimeter
Three months
Manipulation Displacement Score
Time Frame: Six Months.
Joint Displacement Score: Degrees and centimeter
Six Months.
Manipulation Mean Velocity Score
Time Frame: Baseline
Mean Velocity Score: Degrees / seconds and centimeters / seconds
Baseline
Manipulation Mean Velocity Score
Time Frame: One Lesson
Mean Velocity Score: Degrees / seconds and centimeters / seconds
One Lesson
Manipulation Mean Velocity Score
Time Frame: One week
Mean Velocity Score: Degrees / seconds and centimeters / seconds
One week
Manipulation Mean Velocity Score
Time Frame: Four weeks
Mean Velocity Score: Degrees / seconds and centimeters / seconds
Four weeks
Manipulation Mean Velocity Score
Time Frame: Three months
Mean Velocity Score: Degrees / seconds and centimeters / seconds
Three months
Manipulation Mean Velocity Score
Time Frame: Six months.
Mean Velocity Score: Degrees / seconds and centimeters / seconds
Six months.
Manipulation Maximal Velocity Score
Time Frame: Baseline
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
Baseline
Manipulation Maximal Velocity Score
Time Frame: One Lesson
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
One Lesson
Manipulation Maximal Velocity Score
Time Frame: One week
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
One week
Manipulation Maximal Velocity Score
Time Frame: Four weeks
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
Four weeks
Manipulation Maximal Velocity Score
Time Frame: Three months
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
Three months
Manipulation Maximal Velocity Score
Time Frame: Six months.
Maximal Velocity Score: Degrees / seconds and centimeters / seconds
Six months.
Manipulation Mean Acceleration Score
Time Frame: Baseline
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Baseline
Manipulation Mean Acceleration Score
Time Frame: One Lesson
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
One Lesson
Manipulation Mean Acceleration Score
Time Frame: One week
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
One week
Manipulation Mean Acceleration Score
Time Frame: Four weeks
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Four weeks
Manipulation Mean Acceleration Score
Time Frame: Three months
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Three months
Manipulation Mean Acceleration Score
Time Frame: Six months.
Mean Acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Six months.
Manipulation Maximal Acceleration Score
Time Frame: Baseline
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Baseline
Manipulation Maximal Acceleration Score
Time Frame: One Lesson
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
One Lesson
Manipulation Maximal Acceleration Score
Time Frame: One week
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
One week
Manipulation Maximal Acceleration Score
Time Frame: Four weeks
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Four weeks
Manipulation Maximal Acceleration Score
Time Frame: Three months
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Three months
Manipulation Maximal Acceleration Score
Time Frame: Six months.
Maximal acceleration Score: (Degrees / seconds)2 and (centimeters / seconds)2
Six months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Malaga

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2015

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 1, 2016

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 1, 2016

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 12, 2015

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 20, 2015

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 22, 2015

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 13, 2016

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 11, 2016

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • HSF_ISLPerip_Man

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings